Johnson & Johnson

Johnson & Johnson Fined $1.1B
An Arkansas judge has fined Johnson & Johnson and a subsidiary more than $1.1 billion after a jury found the companies downplayed and hid risks associated with an antipsychotic drug.
Johnson & Johnson CEO Retiring in April
Johnson & Johnson's longtime CEO, Bill Weldon, is retiring this April, following an embarrassing string of product recalls that has stretched for more than 2 years, costing the health care giant hundreds of millions of dollars and consumer trust.
Texas Suit Against J&J Over Drug Goes to Trial
Texas prosecutors say drug maker Johnson & Johnson and some of its subsidiaries schemed to plunder hundreds of millions of dollars from the state Medicaid program by overstating the safety of an anti-psychotic drug and should be forced to repay that money plus penalties.

Load More Articles